PG03: Approaches To Optimizing ART Outcomes
Time:8:15 am - 5:00 pm
Location:Room 1 - San Diego Convention Center
R. Stan Williams, M.D. (Chair), University of Florida
G. David Ball, Ph.D., Seattle Reproductive Medicine
Owen K. Davis, M.D., Weill Medical College
Richard T. Scott, M.D., H.C.L.D., Reproductive Medicine Associates of New Jersey
Developed in Cooperation with the Society for Assisted Reproductive Technology
NEEDS ASSESSMENT AND COURSE DESCRIPTION
The field of assisted reproductive technology (ART) is rapidly evolving. In order to obtain the best results for their patients, health care professionals in the field need to be aware of the very latest medical evidence in the science and practice of assisted reproductive technology.
This course targets ART practitioners, laboratory personnel, and nurses. Faculty will review the known effects of ART on offspring, as well as the latest guidelines for determining the number of embryos to transfer in order to achieve the highest possible pregnancy rate, while at the same time reducing the number of multiple pregnancies. Other topics to be covered include optimal ovarian stimulation and embryo selection; U.S. Food and Drug Administration (FDA) donor screening and recent results of FDA inspections; and tips from and techniques of highly successful ART programs.
At the conclusion of this course, participants should be able to:
- Provide patients with appropriate informed consent about the risks of ART and the risks and prevention of multiple pregnancy
- Describe the best protocols for ovarian stimulation in various prognosis patients.
- Discuss how to best cryopreserve oocytes and select the best embryos for transfer.
- Summarize FDA regulations for donor screening and list the most common errors cited by inspectors and how to avoid them.